Latest Options News

Turners Automotive Group has updated its dividend details for the quarter ending March 2025, declaring a fully franked ordinary dividend alongside a supplementary unfranked payout and a Dividend Reinvestment Plan with a 2% discount.

Norwest Minerals has successfully closed a $4.85 million entitlement offer, positioning itself to advance exploration and drilling at its Bulgera gold project. The capital raise aims to unlock the potential of a 218,000-ounce gold resource.

OncoSil Medical has launched a $8.7 million capital raising via a Share Purchase Plan and Placement, seeking shareholder approval for options issuance and a 400:1 share consolidation.

OncoSil Medical has secured $8.7 million through a placement and share purchase plan to fund commercialization of its pancreatic cancer treatment device, aiming for positive cash flow by mid-2026. Near-completion clinical trials could soon unlock broader market access.

Bass Oil Limited reported steady April production and a strategic acquisition of the Vanessa gas field, positioning itself for future gas market entry.

Surefire Resources NL has launched a non-renounceable entitlement offer aiming to raise approximately A$3.87 million to advance its gold and copper projects in Western Australia. The offer includes new shares, bonus shares, and options, targeting eligible shareholders in Australia and New Zealand.

Surefire Resources NL has announced a non-renounceable pro-rata entitlement offer to raise approximately $3.88 million, including free attaching bonus shares and options, aimed at advancing its key gold and copper projects in Western Australia.

Terra Uranium has completed key airborne geophysics surveys and is gearing up for a coordinated 2025 drilling campaign on its Athabasca Basin projects, positioning itself to benefit from a strengthening uranium market.

Mt Malcolm Mines reports promising drilling results at Golden Crown and prepares for an infill program at Dumbarton, aiming to establish maiden resource estimates and advance towards production.

Viva Leisure has taken a strategic 33% stake in Gorilla X Labs, aiming to deepen its footprint in the sports nutrition market and enhance member offerings across its platforms.

PYC Therapeutics has secured approval to escalate dosing in its Phase 1a trial of PYC-003 for Polycystic Kidney Disease, moving closer to patient dosing later this year.

Patriot Resources has successfully raised $2.2 million through an oversubscribed share placement, signaling strong investor confidence as it advances exploration in Zambia and other projects.